Peace Bridge, Calgary, Canada

Propose a project

Process

NEOMED is actively seeking innovative projects that address unmet medical needs. The projects should lead to the potential development of innovative therapeutic approaches, offering differentiated benefits over existing treatments. NEOMED is open to projects in all therapeutic areas of unmet medical need. We welcome the project proposals from academia and biotech, originating within or outside of Quebec.

To submit a project proposal, please complete the form below, providing as much information as possible. KINDLY PROVIDE NON-CONFIDENTIAL INFORMATION ONLY. We strongly encourage you to contact your technology transfer office prior to submitting your idea.

PROJECT SELECTION

NEOMED evaluates the projects along six criteria:

  • Validity of the target: assessment of preclinical and clinical evidence demonstrating potential of target modulation to elicit efficacy in the clinic
  • Drug exposure: assessment of compound properties, where available, demonstrating actual or potential for adequate exposure of the compound at the proposed site of action
  • Safety profile: assessment of the overall safety profile considering both target-related and off-target (compound-related) safety
  • Value to patients: differentiation with respect to available therapies in the proposed patient subpopulation(s)
  • Commercial potential: assessment of competitive positioning and advantages of the proposed projects versus existing products or competitors’ programs
  • Overall feasibility: evaluating the key steps, milestones, timelines, and costs to achieve human proof of concept
    Potential to establish POC in modest Phase 2 study

New opportunities are reviewed at bi-weekly Scouting meetings by all the team to assess the risk associated with each proposal. If a project meets the quality criteria listed above, a project director is assigned to the further evaluation of the project and its due diligence (scientific evaluation, IP, market), For each selected project, we work with the discovery scientists to define the maturation plan to reach a clinical proof-of-concept.

© 2017 NEOMED Institute. All Rights Reserved. // Solutions Web Globalia